Virpax shares rise on expanded licensing deal for experimental drug By: Philadelphia Business Journal via Business Journals March 15, 2022 at 10:06 AM EDT The new drug candidate showed effectives against influenza and SARS-CoV-2 in preclinical studies. Read More >>
